Related Experiment Video
Updated: Oct 6, 2025

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Valve replacement or repair in native mitral valve infective endocarditis-Which is better? A meta-analysis and
Kang He1, Juelin Song1, Hongying Luo1
1Department of Cardiovascular Surgery, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
Background:
Native mitral valve infective endocarditis (IE) plagues patients and surgeons alike because of its high mortality and recurrence rates as well as poor prognosis. Mitral valve repair (MVP) and mitral valve replacement (MVR) are two main surgical methods. However, the question of which benefits patients more remains controversial. Thus, we conducted a meta-analysis to systematically review the two approaches, focusing on the early survival rate and long-term outcomes.
Methods:
A meta-analysis and systematic review were conducted using studies sourced from the PubMed, Embase, and Cochrane literature databases to compare MVP and MVR, with data extracted for baseline characteristics, mortality, survival, recurrent endocarditis, and valve reoperation. Risk ratio (RR) or hazard ratio (HR) values were calculated, and publication bias was tested.
Results:
A total of 17 relevant publications with a total population of 3759 patients, with 1180 patients having undergone MVP and 2579 patients having undergone MVR, respectively, were analyzed. Patients who underwent MVP may benefit from a lower risk of early mortality (RR, 0.51; 95% confidence interval [CI], 0.39-0.66; p < .00001), a higher long-term survival rate (HR, 0.69; 95% CI, 0.58-0.81; p < .001; I2 = 0%), and a lower risk of recurrence (RR, 0.66; 95% CI, 0.40-1.09; p = .10; I2 = 0%). However, a similar risk of reoperation was observed for both groups (RR, 1.02; 95% CI, 0.36-2.91; p = .96; I2 = 43%).
Conclusion:
This meta-analysis suggests that MVP may lead to better outcomes compared to MVR. Among patients with mitral valve IE, MVP can reduce in-hospital mortality, improve long-term survival, and has a lower risk of recurrent endocarditis. As a result, MVP may be suitable as a primary treatment choice and should be considered whenever possible in most IE patients.
Insights
Mitral valve repair (MVP) offers better outcomes than mitral valve replacement (MVR) for infective endocarditis, reducing mortality and improving survival. MVP is a suitable primary treatment choice for most patients.
Area of Science:
- Cardiovascular Surgery
- Infectious Diseases
- Medical Statistics
Background:
- Native mitral valve infective endocarditis (IE) presents significant challenges due to high mortality and recurrence rates.
- Surgical interventions, primarily mitral valve repair (MVP) and mitral valve replacement (MVR), are standard treatments, but their comparative efficacy remains debated.
Purpose of the Study:
- To systematically review and compare the early and long-term outcomes of MVP versus MVR in patients with native mitral valve IE.
- To determine which surgical approach offers superior survival rates and reduces the risk of complications.
Main Methods:
- A meta-analysis and systematic review of studies from PubMed, Embase, and Cochrane databases.
- Data extraction included baseline characteristics, mortality, survival, recurrent endocarditis, and reoperation rates.
- Risk ratios (RR) and hazard ratios (HR) were calculated to assess treatment effects.
Main Results:
- Analysis of 17 studies involving 3759 patients (1180 MVP, 2579 MVR).
- MVP was associated with significantly lower early mortality (RR, 0.51) and improved long-term survival (HR, 0.69).
- MVP showed a trend towards lower recurrence risk (RR, 0.66), with similar reoperation rates compared to MVR.
Conclusions:
- Mitral valve repair (MVP) appears to yield better outcomes than mitral valve replacement (MVR) for native mitral valve infective endocarditis.
- MVP is recommended as a primary treatment option, potentially reducing in-hospital mortality, enhancing long-term survival, and lowering recurrence risk.
More Related Videos
Related Concept Videos
Mitral Stenosis III: Medical Management
Mitral Regurgitation III: Medical Management
Mitral Valve Prolapse II: Assessment and Management
Endocarditis III: Medical Management
Mitral Regurgitation IV: Nursing Management
Mitral Valve Prolapse I: Introduction

